BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Inscopix and NeuroNexus to Collaborate on Integrated Brain Electrophysiology and Imaging Device

  Inscopix and NeuroNexus to Collaborate on Integrated Brain Electrophysiology and Imaging Device

  November 9, 2021

   · 

  3 min read
• Genetown

  Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

  Pear Therapeutics Announces Inclusion of reSET ® and reSET-O ® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

  November 9, 2021

   · 

  10 min read
• Drug Development

  Noxopharm Announces DARRT-2 Clinical Trial in U.S.

  Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced with patient enrollment in the U.S.

  November 9, 2021

   · 

  2 min read
• Business

  Enigma Biointelligence Collaborates with Siemens Healthineers CLIA Laboratory to Provide Laboratory Services in the Field of Neurodegenerative Diseases

  Enigma Biomedical Intelligence (EBI) today announced that it is working together with the Siemens Healthineers CLIA Laboratory in Berkeley, CA, to provide blood testing capabilities to academic and commercial institutions interested in research in the field of neuro-degenerative diseases.

  November 9, 2021

   · 

  1 min read
• Business

  Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates

  Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates

  November 9, 2021

   · 

  17 min read
• Bio NC

  Dentsply Sirona to Present at Upcoming Virtual Investor Conferences

  DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) - announced today that the Company will present at three upcoming investor conferences.

  November 9, 2021

   · 

  1 min read
• Business

  Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference CallCall Scheduled for Monday, November 15, 2021 at 5:00 pm ET

  Vivos Therapeutics, Inc. today announced that it plans to release financial results for the third quarter ended September 30, 2021 after market close on Monday, November 15, 2021.

  November 9, 2021

   · 

  3 min read
• Business

  Ocugen Provides Business Update and Third Quarter 2021 Financial Results

  Ocugen Provides Business Update and Third Quarter 2021 Financial Results

  November 9, 2021

   · 

  11 min read
• Biotech Bay

  Rigel to Participate in Two Upcoming Investor Conferences

  Rigel Pharmaceuticals, Inc. today announced that Dean Schorno , the company’s chief financial officer, will participate in the following virtual investor conferences in November: Jefferies Virtual London Healthcare Conference ( November 18-19, 2021 )

  November 9, 2021

   · 

  2 min read
• Business

  Neuronetics Reports Third Quarter 2021 Financial and Operating Results

  Neuronetics, Inc. today announced its financial and operating results for the third quarter of 2021.

  November 9, 2021

   · 

  15 min read